---
title: "SMTI: Q2 2026 revenue grew 9% to $28.1M, with a 93% gross margin and a pending merger with MiMedx"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295581744.md"
description: "Sanara MedTech (SMTI) reported Q2 2026 revenue of $28.1M, up 9%, with a 93% gross margin and adjusted EBITDA of $5.0M. Despite these gains, higher SG&A and interest expenses resulted in a net loss of $0.4M. The company also announced a merger with MiMedx Group, consolidating operations into a single surgical-focused segment."
datetime: "2026-08-11T21:12:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295581744.md)
  - [en](https://longbridge.com/en/news/295581744.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295581744.md)
generator: "portal-rs"
---

# SMTI: Q2 2026 revenue grew 9% to $28.1M, with a 93% gross margin and a pending merger with MiMedx

Q2 2026 saw 9% revenue growth to $28.1M, driven by soft tissue repair products, with gross margin at 93%. Adjusted EBITDA rose to $5.0M, but higher SG&A and interest led to a net loss of $0.4M. A merger with MiMedx Group was announced, and the company now operates as a single surgical-focused segment.

Original document: Sanara MedTech Inc. \[SMTI\] SEC 10-Q Quarterly Report — Aug. 19 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [SMTI.US](https://longbridge.com/en/quote/SMTI.US.md)
- [MDXG.US](https://longbridge.com/en/quote/MDXG.US.md)

## Related News & Research

- [Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI](https://longbridge.com/en/news/296019613.md)
- [MiMedx Group's (MDXG) "Overweight" Rating Reaffirmed at Cantor Fitzgerald](https://longbridge.com/en/news/296103205.md)
- [Sanara MedTech koreksi biaya terminasi merger; ubah jadi USD 9,66 juta dari USD 22,54 juta](https://longbridge.com/en/news/295573503.md)
- [Surgical Science Sweden (OM:SUS) Stock Rich Margins Meet A Durability Question](https://longbridge.com/en/news/296529240.md)
- [MiMedx Group Q2 Earnings Call Highlights](https://longbridge.com/en/news/294272580.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**